Lin Cai

Efficacy and safety of adalimumab in Chinese patients with moderate‐to‐severe plaque psoriasis: results from a phase 3, randomized, placebo‐controlled, double‐blind study

Lin Cai, Jie Gu, Jie Zheng et al. · Journal of the European Academy of Dermatology and Venereology · 2016 · 96 citations · Full text

Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasis

Lin Cai, Jianzhong Zhang, Xu Yao et al. · Chinese Medical Journal · 2020 · 45 citations · Full text

Distribution of Serotypes, Genotypes, and Resistance Determinants among Macrolide-Resistant <i>Streptococcus pneumoniae</i> Isolates

Xiaoping Xu, Lin Cai, Meng Xiao et al. · Antimicrobial Agents and Chemotherapy · 2010 · 37 citations · Full text

A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis

Lin Cai, Gen-Hui Chen, Qianjin Lu et al. · Chinese Medical Journal · 2020 · 36 citations · Full text

Risk factors for survival in patients with von Hippel-Lindau disease

Jiangyi Wang, Shuanghe Peng, Teng Li et al. · Journal of Medical Genetics · 2018 · 29 citations